Ultragenyx Pharmaceutical Inc.
IPOUltragenyx—Treatment of Rare and Ultrarare Genetic Diseases
Public · Novato, United States · $120.0M raised
- Headquarters
- Novato, California
- Employees
- 1001–5000
- Business Model
- B2C
- Website
- ultragenyx.com
- Total Funding
- $120.0M
- Last Round
- $75.0M Series BDec 2012
- Rounds
- 2
- Type
- Public
About
Biopharmaceutical company focused on developing treatments for rare and ultra-rare genetic diseases.
Summary
Ultragenyx Pharmaceutical Inc. is a Biotech company based in Novato, United States. It has raised $120.0M in total across 2 rounds, most recently a $75.0M Series B round in Dec 2012. Investors include HealthCap and Takeda (JP).
Tech & App Stack
6 technologies & apps tracked
Create a free account to track companies, build lists, and unlock premium data like the full tech & app stack.
Sign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Funding History
Feb 2014
Sign up to see all 3 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biopharmaceutical services company
Specialty pharmaceutical company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...